Foresite Capital Management II’s Aerie Pharmaceuticals AERI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-253,698	Closed	-$3.42M	–	6
2020 Q1	$3.42M	Sell	253,698 -1,419,016	-85%	-$26.9M	0.8%	4
2019 Q4	$40.4M	Hold	1,672,714	–	–	6.66%	2
2019 Q3	$32.1M	Hold	1,672,714	–	–	6.8%	3
2019 Q2	$49.4M	Hold	1,672,714	–	–	27.79%	2
2019 Q1	$79.5M	Hold	1,672,714	–	–	35.87%	1
2018 Q4	$60.4M	Buy	1,672,714 +207,965	+14%	+$9.76M	32%	2
2018 Q3	$90.2M	Hold	1,464,749	–	–	33.37%	1
2018 Q2	$98.9M	Sell	1,464,749 -207,965	-12%	-$11.6M	34.86%	1
2018 Q1	$90.7M	Hold	1,672,714	–	–	31.65%	2
2017 Q4	$99.9M	Hold	1,672,714	–	–	34.92%	2
2017 Q3	$81.3M	Hold	1,672,714	–	–	32.95%	2
2017 Q2	$87.9M	Buy	1,672,714 +99,688	+6%	+$4.64M	40.27%	1
2017 Q1	$71.3M	Sell	1,573,026 -1,723	-0.1%	-$76.8K	30.6%	2
2016 Q4	$59.6M	Sell	1,574,749 -97,965	-6%	-$3.7M	29.91%	2
2016 Q3	$63.1M	Buy	1,672,714 +697,429	+72%	+$15.4M	30.14%	1
2016 Q2	$17.2M	Buy	975,285 +25,913	+3%	+$419K	11.73%	3
2016 Q1	$11.5M	Buy	949,372 +211,011	+29%	+$3.34M	5.73%	8
2015 Q4	$18M	Sell	738,361 -167,956	-19%	-$3.92M	6.23%	6
2015 Q3	$16.1M	Buy	906,317 +101,100	+13%	+$1.83M	5.13%	6
2015 Q2	$14.2M	Buy	805,217 +595,150	+283%	+$10.9M	5%	8
2015 Q1	$6.58M	Sell	210,067 -10,000	-5%	-$290K	3.9%	6
2014 Q4	$6.42M	Buy	+220,067	New	+$5.58M	4.57%	7